Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Asumi Okumura, Eiji Kondo, Michiko Kubo-Kaneda, Kenta Yoshida & Tomoaki Ikeda. (2022) Efficacy of minodronic acid for the prevention of osteoporosis in premenopausal women with gynaecologic disease who undergo bilateral oophorectomy: a single-centre, non-randomised controlled, experimental study. Journal of Obstetrics and Gynaecology 42:8, pages 3591-3599.
Read now
Read now
Tsuyoshi Ohishi & Yukihiro Matsuyama. (2018) Minodronate for the treatment of osteoporosis. Therapeutics and Clinical Risk Management 14, pages 729-739.
Read now
Read now
Aska Toda, Kenjiro Sawada, Akihiko Yoshimura, Erika Nakatsuka, Hiromasa Kuroda, Katsumi Kozasa, Mayuko Miyamoto, Kae Hashimoto, Seiji Mabuchi & Tadashi Kimura. (2017) Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene. International Journal of Women's Health 9, pages 821-825.
Read now
Read now
Atsushi Imai, Kazutoshi Matsunami, Satoshi Ichigo & Hiroshi Takagi. (2016) Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study. Gynecological Endocrinology 32:3, pages 250-252.
Read now
Read now
Xuefei Gao, Liang Zhu, Chenglin Dong, Xiaoning Wang, Wenli Zhao, Xiaoyu Zhao & Yanfei Wang. Investigation on the structural characteristics and polymorphic transformation mechanism of polymorphic hydrates: a case of minodronic acid monohydrate. Phase Transitions 0:0, pages 1-19.
Read now
Read now
Articles from other publishers (24)
Deepika Geedkar, Ashok Kumar & Pratibha Sharma. (2022)
Molecular Iodine-Catalyzed Synthesis of Imidazo[1,2-
a
]Pyridines: Screening of Their
In Silico
Selectivity, Binding Affinity to Biological Targets, and Density Functional Theory Studies Insight
. ACS Omega 7:26, pages 22421-22439.
Crossref
Crossref
Shi Anan, Zou Qiaogen & Gao Pan. (2022) Identification, Characterization, and the Determination of Process-related
Impurities in Minodronic Acid Bulk Drug. Current Pharmaceutical Analysis 18:3, pages 325-335.
Crossref
Crossref
Svetlana O. Kushch, Marina V. Goryaeva, Elena A. Surnina, Yanina V. Burgart, Marina A. Ezhikova, Mikhail I. Kodess, Pavel A. Slepukhin & Victor I. Saloutin. (2021)
Multicomponent Domino Reactions for the Synthesis of Variable Hydrogenated Imidazo[1,2‐
a
]pyridines
. Asian Journal of Organic Chemistry 11:2.
Crossref
Crossref
Wei Chen & Zheng Li. (2021)
One-Pot Synthesis of 3-Methyl-2-arylimidazo[1,2-
a
]pyridines Using Calcium Carbide as an Alkyne Source
. The Journal of Organic Chemistry 87:1, pages 76-84.
Crossref
Crossref
Joseph Cusimano. (2022) Rabeprazole. WikiJournal of Medicine 9:1, pages 6.
Crossref
Crossref
Marcelo Straesser Franco, Sumbal Saba, Jamal Rafique & Antonio Luiz Braga. (2021)
KIO
4
‐mediated Selective Hydroxymethylation/Methylenation of Imidazo‐Heteroarenes: A Greener Approach
. Angewandte Chemie International Edition 60:34, pages 18454-18460.
Crossref
Crossref
Marcelo Straesser Franco, Sumbal Saba, Jamal Rafique & Antonio Luiz Braga. (2021)
KIO
4
‐mediated Selective Hydroxymethylation/Methylenation of Imidazo‐Heteroarenes: A Greener Approach
. Angewandte Chemie 133:34, pages 18602-18608.
Crossref
Crossref
Masaki Kobayashi, Kenjiro Sawada, Akihiko Yoshimura, Misa Yamamoto, Aasa Shimizu, Kotaro Shimura, Naoko Komura, Mayuko Miyamoto, Kyoso Ishida & Tadashi Kimura. (2020) Clinical effects of switching from minodronate to denosumab treatment in patients with postmenopausal osteoporosis: a retrospective study. BMC Women's Health 20:1.
Crossref
Crossref
Santosh K. Gudimella, Amanpreet Kaur, Ram Kumar & Sampak Samanta. (2020) CuCl2-catalyzed N O bond cleavage of oxime esters: Approach to imidazoheterocycles and furo[3,2-c]chromenyl fused imidazoles. Tetrahedron Letters 61:31, pages 152147.
Crossref
Crossref
Mohamed Sharshar, Toshimi Kaido, Hisaya Shirai, Shinya Okumura, Siyuan Yao, Yosuke Miyachi, Sena Iwamura, Naoko Kamo, Shintaro Yagi, Mahmoud Macshut & Shinji Uemoto. (2020) Impact of the preoperative bone mineral density on the outcomes after resection of pancreatic cancer. Surgery Today 50:7, pages 757-766.
Crossref
Crossref
Gagandeep Kour Reen, Ashok Kumar & Pratibha Sharma. (2019) Recent advances on the transition-metal-catalyzed synthesis of imidazopyridines: an updated coverage. Beilstein Journal of Organic Chemistry 15, pages 1612-1704.
Crossref
Crossref
Davinder Singh, Gulshan Kumar, Divya Dheer, Jyoti, Manoj Kushwaha, Qazi Naveed Ahmed & Ravi Shankar. (2019)
BCl
3
-Mediated C–N, C–S, and C–O Bond Formation of Imidazo[1,2-
a
]pyridine Benzylic Ethers
. ACS Omega 4:3, pages 4530-4539.
Crossref
Crossref
Yosuke Miyachi, Toshimi Kaido, Siuan Yao, Hisaya Shirai, Atsushi Kobayashi, Yuhei Hamaguchi, Naoko Kamo, Shintaro Yagi & Shinji Uemoto. (2018) Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma. World Journal of Surgery 43:3, pages 920-928.
Crossref
Crossref
Dafang Zhong & Yunting Zhu. 2019. Sample Preparation in LC‐MS Bioanalysis. Sample Preparation in LC‐MS Bioanalysis
260
274
.
Yuheng Wang, Bingbing Zhang, Yinying Zheng, Qiaoning Ma, Qiang Sui & Xinsheng Lei. (2019) Practical and scalable preparation of Minodronic acid and Zolpidem from 2-chloroimidazole[1,2-a]pyridines. Tetrahedron 75:8, pages 1064-1071.
Crossref
Crossref
Kosaku Nitta, Aiji Yajima & Ken Tsuchiya. (2017) Management of Osteoporosis in Chronic Kidney Disease. Internal Medicine 56:24, pages 3271-3276.
Crossref
Crossref
J. Zhou, X. Ma, T. Wang & S. Zhai. (2016) Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Osteoporosis International 27:11, pages 3289-3300.
Crossref
Crossref
Elaine Y.N. Cheung, Kathryn C.B. Tan, Ching-Lung Cheung & Annie W.C. Kung. (2016) Osteoporosis in East Asia: Current issues in assessment and management. Osteoporosis and Sarcopenia 2:3, pages 118-133.
Crossref
Crossref
Soumen Payra, Arijit Saha, Chia-Ming Wu, Balaranjan Selvaratnam, Thorn Dramstad, Luther Mahoney, Sant Kumar Verma, Suresh Thareja, Ranjit Koodali & Subhash Banerjee. (2016) Fe–SBA-15 catalyzed synthesis of 2-alkoxyimidazo[1,2-a]pyridines and screening of their in silico selectivity and binding affinity to biological targets. New Journal of Chemistry 40:11, pages 9753-9760.
Crossref
Crossref
Yong Yang, Cai Liu, Yifan Zhang, Lei Zhou, Dafang Zhong & Xiaoyan Chen. (2015) On-cartridge derivatization coupled with solid-phase extraction for the ultra-sensitive determination of minodronic acid in human plasma by LC–MS/MS method. Journal of Pharmaceutical and Biomedical Analysis 114, pages 408-415.
Crossref
Crossref
Marina V. Goryaeva, Yanina V. Burgart, Yulia S. Kudyakova, Marina A. Ezhikova, Mikhail I. Kodess, Pavel A. Slepukhin & Victor I. Saloutin. (2015)
Three-Component Synthesis of 7-Hydroxy-7-polyfluoroalkylhexahydroimidazo[1,2-
a
]pyridin-5(1
H
)-ones
. European Journal of Organic Chemistry 2015:28, pages 6306-6314.
Crossref
Crossref
Yan Zhang, Jin Shao, Zhi Wang, Tieyi Yang, Shuyi Liu, Yue Liu, Xinbing Fan & Weiguang Ye. (2015) Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene 557:2, pages 209-214.
Crossref
Crossref
Annalisa Airoldi, Piergiorgio Bettoni, Monica Donnola, Gianluca Calestani & Corrado Rizzoli. (2015)
Crystal structure of zwitterionic 3-(2-hydroxy-2-phosphonato-2-phosphonoethyl)imidazo[1,2-
a
]pyridin-1-ium monohydrate (minodronic acid monohydrate): a redetermination
. Acta Crystallographica Section E Crystallographic Communications 71:1, pages 51-54.
Crossref
Crossref
A. Sakai, S. Ikeda, N. Okimoto, H. Matsumoto, K. Teshima, Y. Okazaki, F. Fukuda, S. Arita, H. Tsurukami, M. Nagashima & T. Yoshioka. (2014) Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study. Osteoporosis International 25:9, pages 2245-2253.
Crossref
Crossref